Crinetics Pharmaceuticals Inc
(CRNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 143 | 1,031 | 361 | 0 | 0 |
| Gross Profit | 143 | 1,031 | 361 | 0 | N/A |
| Operating Expenses | 142,729 | 130,143 | 111,766 | 94,745 | 87,797 |
| Operating Income | -142,586 | -129,112 | -111,405 | -94,745 | -87,797 |
| Other Income | 12,495 | 13,475 | 14,631 | 14,150 | 10,969 |
| Pre-tax Income | -130,091 | -115,637 | -96,774 | -80,595 | -76,828 |
| Net Income Continuous | -130,091 | -115,637 | -96,774 | -80,595 | -76,828 |
| Net Income | $-130,091 | $-115,637 | $-96,774 | $-80,595 | $-76,828 |
| EPS Basic Total Ops | -1.38 | -1.23 | -1.04 | -0.86 | -0.96 |
| EPS Basic Continuous Ops | -1.38 | -1.23 | -1.04 | -0.87 | -0.96 |
| EPS Diluted Total Ops | -1.38 | -1.23 | -1.04 | -0.86 | -0.96 |
| EPS Diluted Continuous Ops | -1.38 | -1.23 | -1.04 | -0.87 | -0.96 |
| EPS Diluted Before Non-Recurring Items | -1.38 | -1.23 | -1.04 | -0.88 | -0.96 |
| EBITDA(a) | $-145,175 | $-132,867 | $-114,856 | $-98,120 | $-90,540 |